These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Seroprevalence of HPV 6, 11, 16 and 18 and correlates of exposure in unvaccinated women aged 16-64 years in Puerto Rico. Ortiz AP, Tortolero-Luna G, Romaguera J, Pérez CM, González D, Muñoz C, González L, Marrero E, Suárez E, Palefsky JM, Panicker G, Unger ER. Papillomavirus Res; 2018 Jun; 5():109-113. PubMed ID: 29555601 [Abstract] [Full Text] [Related]
26. Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates. Lang Kuhs KA, Porras C, Schiller JT, Rodriguez AC, Schiffman M, Gonzalez P, Wacholder S, Ghosh A, Li Y, Lowy DR, Kreimer AR, Poncelet S, Schussler J, Quint W, van Doorn LJ, Sherman ME, Sidawy M, Herrero R, Hildesheim A, Safaeian M, Costa Rica Vaccine Trial Group. Am J Epidemiol; 2014 Sep 15; 180(6):599-607. PubMed ID: 25139208 [Abstract] [Full Text] [Related]
27. Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial. Kreimer AR, Sampson JN, Porras C, Schiller JT, Kemp T, Herrero R, Wagner S, Boland J, Schussler J, Lowy DR, Chanock S, Roberson D, Sierra MS, Tsang SH, Schiffman M, Rodriguez AC, Cortes B, Gail MH, Hildesheim A, Gonzalez P, Pinto LA, Costa Rica HPV Vaccine Trial (CVT) Group. J Natl Cancer Inst; 2020 Oct 01; 112(10):1038-1046. PubMed ID: 32091594 [Abstract] [Full Text] [Related]
33. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination. Brotherton JML, Tabrizi SN, Phillips S, Pyman J, Cornall AM, Lambie N, Anderson L, Cummings M, Payton D, Scurry JP, Newman M, Sharma R, Saville M, Garland SM. Int J Cancer; 2017 Oct 15; 141(8):1576-1584. PubMed ID: 28677147 [Abstract] [Full Text] [Related]
35. Correlation between viral load, multiplicity of infection, and persistence of HPV16 and HPV18 infection in a Dutch cohort of young women. van der Weele P, van Logchem E, Wolffs P, van den Broek I, Feltkamp M, de Melker H, Meijer CJ, Boot H, King AJ. J Clin Virol; 2016 Oct 15; 83():6-11. PubMed ID: 27522635 [Abstract] [Full Text] [Related]
36. Immunogenicity and safety of the bivalent HPV vaccine in female patients with juvenile idiopathic arthritis: a prospective controlled observational cohort study. Heijstek MW, Scherpenisse M, Groot N, Tacke C, Schepp RM, Buisman AM, Berbers GA, van der Klis FR, Wulffraat NM. Ann Rheum Dis; 2014 Aug 15; 73(8):1500-7. PubMed ID: 23723319 [Abstract] [Full Text] [Related]
37. Incidence and predictors of human papillomavirus-6, -11, -16, and -18 infection in young norwegian women. Kim S, Arduino JM, Roberts CC, Marsico M, Liaw KL, Skjeldestad FE. Sex Transm Dis; 2011 Jul 15; 38(7):587-97. PubMed ID: 21301390 [Abstract] [Full Text] [Related]
38. Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species. Gambhira R, Gravitt PE, Bossis I, Stern PL, Viscidi RP, Roden RB. Cancer Res; 2006 Dec 01; 66(23):11120-4. PubMed ID: 17145854 [Abstract] [Full Text] [Related]